Skip to main content
TrimSoMoEverything GLP-1, in one place
Program Profile

Success by Sesame

Is Success by Sesame listed in FDA warning letters?

No GLP-1 FDA warning letters to Success by Sesame appear in our dataset (FDA.gov letters 2023–2026).

Key facts

  • •Care model: Telehealth care program.
  • •Medications discussed: Wegovy (semaglutide), Zepbound (tirzepatide), Wegovy Tablets (oral semaglutide), Foundayo (orforglipron), Saxenda (liraglutide).
  • •State availability: Confirm directly with program. Note: Provider availability and terms can vary. Confirm state access and all fees directly.

A telehealth weight-management care program.

At a glance
Care model
Telehealth care program
Medications discussed
Wegovy (semaglutide), Zepbound (tirzepatide), Wegovy Tablets (oral semaglutide), Foundayo (orforglipron), Saxenda (liraglutide)
Availability
Confirm with program
Provider availability and terms can vary. Confirm state access and all fees directly.

No FDA Warning Letters Found in Register

As of 2026-11-05, no FDA warning letters involving GLP-1 medications (semaglutide, tirzepatide) were identified in official FDA compliance records for this company or its operating corporate entities (Sesame, Inc.).

(Note: The absence of a warning letter in this dataset reflects public FDA records as of the date indicated and does not constitute a safety endorsement, certification of clinical quality, or operational guarantee.)

Questions to ask the program

Before you sign up

Read the program's own terms on its website, including how to cancel.

  • •Do the program terms change after the first month or refill?
  • •Are medication shipping and lab work handled by the program or separately?
  • •What notice does the program require to cancel?
Sources

Source records

Success by Sesame weight loss program page

Last checked Nov 4, 2026

Open original source

Sesame Zepbound program page

Last checked Nov 7, 2026

Open original source

Sesame Oral Wegovy Pill program page

Last checked Nov 7, 2026

Open original source

Sesame Foundayo program page

Last checked Nov 7, 2026

Open original source
Pre-Enrollment Verification

Evaluate Eligibility & Coverage Before Enrolling in Success by Sesame

Confirm your clinical qualification and test out-of-pocket medication expenses before paying consultation or subscription fees to Success by Sesame.

All Decision Tools
Financial Modeling

Copay & Savings Card Rules

Model out-of-pocket copays for Zepbound and Wegovy under commercial plans ($25/mo caps) vs. self-pay cash channels.

Clinical Prep

Baseline Lab & Safety Screen

Legitimate telehealth prescribers require baseline kidney and A1c bloodwork. Review required panels and boxed warnings before your intake.

Indication Check

FDA BMI Indication Gauge

Verify whether your BMI meets official FDA prescribing standards (BMI ≥30 or ≥27 with comorbidity) before paying non-refundable fees.

100% Client-Side Privacy: No personal health data is shared with providers or third parties.Independent consumer guidance based on official DailyMed FDA prescribing archives.
Patient Guidance & Safety

Telehealth Navigation & Checklist

Evaluating a digital clinic? Review our clinical checklists for verifying state licensure, required blood work, and navigating insurance coverage.

Notice outdated or missing information? Submit a source-linked correction request.